Men with localized, intermediate risk prostate cancer will be randomized to undergo either radical prostatectomy or the TULSA procedure, with a follow-up of 10 years in this multi-centered randomized control trial. This study will determine whether the TULSA procedure is as effective and more safe compared to radical prostatectomy.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Safety endpoint - proportion of patients who maintain both urinary continence and erectile potency
Timeframe: 12 months post-treatment
Efficacy endpoint - proportion of patients free from treatment failure
Timeframe: 36 months post-treatment